Erica Campbell
Psychiatry · Bradenton, FLNPI 1407418650
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 392 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,977, 8.4 times the $354 reported in 2019. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 392 payments — averaging $20.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- AbbVie$984
- Neurocrine Biosciences, Inc.$910
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$836
- Otsuka America Pharmaceutical, Inc.$751
- Axsome Therapeutics, Inc.$712
- plus $3K from 17 others
What the payments were for
- Food & beverage$8,080100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 56 | $1,274 |
| AbbVie(2 entities) | 49 | $984 |
| Neurocrine Biosciences, Inc. | 44 | $910 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 58 | $836 |
| Otsuka America Pharmaceutical, Inc. | 41 | $751 |
| Axsome Therapeutics, Inc. | 33 | $712 |
| Teva Pharmaceuticals USA, Inc. | 23 | $502 |
| Johnson & Johnson | 16 | $438 |
| Indivior Inc. | 13 | $286 |
| E.r. Squibb & Sons, L.L.C. | 11 | $266 |
| Tempus AI, Inc | 12 | $193 |
| Braeburn Inc. | 8 | $186 |
| Vanda Pharmaceuticals Inc. | 7 | $175 |
| Sunovion Pharmaceuticals Inc. | 1 | $109 |
| Lundbeck LLC | 4 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $97 |
| American Orthodontics Corporation | 1 | $95 |
| Supernus Pharmaceuticals, Inc. | 3 | $57 |
| Ironshore Pharmaceuticals Inc. | 2 | $36 |
| Almatica Pharma LLC | 2 | $31 |
| Tris Pharma Inc | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Corium, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,089 in reported general payments places this provider in the 90th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 11 | $8,556 |
| Aripiprazole | 43 | $2,132 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $1,200 |
| Ziprasidone Hcl | 12 | $875 |
| Carbamazepine | 13 | $835 |
| Quetiapine Fumarate | 31 | $629 |
| Buspirone Hcl | 35 | $605 |
| Bupropion XlBupropion Hcl | 13 | $539 |
| Olanzapine | 37 | $479 |
| Hydroxyzine Pamoate | 20 | $420 |
| Duloxetine Hcl | 15 | $397 |
| Trazodone Hcl | 62 | $383 |
| Mirtazapine | 17 | $381 |
| Lamotrigine | 12 | $370 |
| Clonazepam | 31 | $367 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $97 | $8,55611 claims |
| Almatica Pharma LLCSertraline Hcl | $31 | $15935 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Bradenton
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
- David SheehanTampa$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.